AIM ImmunoTech Inc.

AIM ImmunoTech Inc.verified

AIM

Price:

$1.47

Market Cap:

$4.19M

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of nat...[Read more]

Industry

Biotechnology

IPO Date

1996-07-12

Stock Exchange

AMEX

Ticker

AIM

The ROE as of December 2025 (TTM) for AIM ImmunoTech Inc. (AIM) is 353.89%

According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current ROE is 353.89%. This represents a change of 119.76% compared to the average of 161.04% of the last 4 quarters.

AIM ImmunoTech Inc. (AIM) Historical ROE (quarterly & annually)

How has AIM ROE performed in the past?

The mean historical ROE of AIM ImmunoTech Inc. over the last ten years is 42.79%. The current 353.89% ROE has changed 727.11% with respect to the historical average. Over the past ten years (40 quarters), AIM's ROE was at its highest in in the December 2024 quarter at 451.36%. The ROE was at its lowest in in the September 2024 quarter at -127.06%.

Quarterly (TTM)
Annual

Average

42.79%

Median

-62.66%

Minimum

-283.00%

Maximum

1.31%

AIM ImmunoTech Inc. (AIM) ROE by Quarter and Year

Discovering the peaks and valleys of AIM ImmunoTech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 459.85%

Maximum Annual ROE = 1.31%

Minimum Annual Increase = -562.95%

Minimum Annual ROE = -283.00%

Quarterly (TTM)
Annual
YearROEChange
20241.31%-562.95%
2023-283.00%459.85%
2022-50.55%50.32%
2021-33.63%43.14%
2020-23.49%-71.99%
2019-83.88%-55.78%
2018-189.66%99.86%
2017-94.90%96.05%
2016-48.41%-35.25%
2015-74.76%7.13%

AIM ImmunoTech Inc. (AIM) Average ROE

How has AIM ROE performed in the past?

The current ROE of AIM ImmunoTech Inc. (AIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

325.53%

5-year avg

183.89%

10-year avg

42.79%

AIM ImmunoTech Inc. (AIM) ROE vs. Peers

How is AIM’s ROE compared to its peers?

AIM ImmunoTech Inc.’s ROE is greater than KALA BIO, Inc. (-2323.94%), greater than Oragenics, Inc. (-4705.41%), greater than Pasithea Therapeutics Corp. (-99.53%), greater than VYNE Therapeutics Inc. (-80.55%), greater than Quoin Pharmaceuticals, Ltd. (-210.51%), greater than Ensysce Biosciences, Inc. (-386.70%), greater than XTL Biopharmaceuticals Ltd. (-33.89%), greater than Alaunos Therapeutics, Inc. (-167.97%), greater than Can-Fite BioPharma Ltd. (-182.93%), greater than Soligenix, Inc. (-274.80%),

Build a custom stock screener for AIM ImmunoTech Inc. (AIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AIM ImmunoTech Inc. (AIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is AIM ImmunoTech Inc.'s ROE?

How is the ROE calculated for AIM ImmunoTech Inc. (AIM)?

What is the highest ROE for AIM ImmunoTech Inc. (AIM)?

What is the 3-year average ROE for AIM ImmunoTech Inc. (AIM)?

What is the 5-year average ROE for AIM ImmunoTech Inc. (AIM)?

How does the current ROE for AIM ImmunoTech Inc. (AIM) compare to its historical average?